BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 26033719)

  • 21. Testing susceptibility of multidrug-resistant Mycobacterium tuberculosis to second-line drugs by use of blood agar.
    Satana D; Coban AY; Uzun M
    J Clin Microbiol; 2010 Nov; 48(11):4291-3. PubMed ID: 20826642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variation in missed doses and reasons for discontinuation of anti-tuberculosis drugs during hospital treatment for drug-resistant tuberculosis in South Africa.
    Pietersen E; Anderson K; Cox H; Dheda K; Bian A; Shepherd BE; Sterling TR; Warren RM; van der Heijden YF
    PLoS One; 2023; 18(2):e0281097. PubMed ID: 36780443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between mutations in a
    Zeng R; He L; Zhang B; Hu Y; Yu J; Yang S; Gu J; Wu Z; Deng J
    Emerg Microbes Infect; 2023 Dec; 12(2):2276339. PubMed ID: 38029724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Second-line drug susceptibilities of multidrug-resistant tuberculosis strains isolated in Thailand: an update.
    Chaiprasert A; Srimuang S; Tingtoy N; Makhao N; Sirirudeeporn P; Tomnongdee N; Theankeaw O; Charoensook S; Leechawengwongs M; Prammananan T
    Int J Tuberc Lung Dis; 2014 Aug; 18(8):961-3. PubMed ID: 25199012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic Susceptibility Patterns of Mycobacterium tuberculosis Isolates from Guizhou Province of China Against 13 Antituberculosis Drugs.
    Li N; Liao X; Chen L; Wang J; Liu M; Zhang H
    Microb Drug Resist; 2015 Jun; 21(3):292-6. PubMed ID: 25599413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. dfrA thyA Double Deletion in para-Aminosalicylic Acid-Resistant Mycobacterium tuberculosis Beijing Strains.
    Moradigaravand D; Grandjean L; Martinez E; Li H; Zheng J; Coronel J; Moore D; Török ME; Sintchenko V; Huang H; Javid B; Parkhill J; Peacock SJ; Köser CU
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3864-7. PubMed ID: 27021327
    [No Abstract]   [Full Text] [Related]  

  • 27. [M. tuberculosis drug resistance and occurrence in patients with pulmonary tuberculosis].
    Novozhylova IO
    Lik Sprava; 2003 Dec; (8):16-20. PubMed ID: 14964999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycobacterium tuberculosis Arylamine N-Acetyltransferase Acetylates and Thus Inactivates para-Aminosalicylic Acid.
    Wang X; Yang S; Gu J; Deng J
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7505-7508. PubMed ID: 27671064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania.
    Mpagama SG; Houpt ER; Stroup S; Kumburu H; Gratz J; Kibiki GS; Heysell SK
    BMC Infect Dis; 2013 Sep; 13():432. PubMed ID: 24034230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbial sensor for drug susceptibility testing of Mycobacterium tuberculosis.
    Zhang ZT; Wang DB; Li CY; Deng JY; Zhang JB; Bi LJ; Zhang XE
    J Appl Microbiol; 2018 Jan; 124(1):286-293. PubMed ID: 29055163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda.
    Umubyeyi A; Rigouts L; Shamputa IC; Dediste A; Struelens M; Portaels F
    Int J Infect Dis; 2008 Mar; 12(2):152-6. PubMed ID: 17950021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and Analysis of Bacterial Folate Metabolism Intermediates and Antifolates.
    Dawadi S; Kordus SL; Baughn AD; Aldrich CC
    Org Lett; 2017 Oct; 19(19):5220-5223. PubMed ID: 28926267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of para-aminosalicylic acid in HIV-uninfected and HIV-coinfected tuberculosis patients receiving antiretroviral therapy, managed for multidrug-resistant and extensively drug-resistant tuberculosis.
    de Kock L; Sy SK; Rosenkranz B; Diacon AH; Prescott K; Hernandez KR; Yu M; Derendorf H; Donald PR
    Antimicrob Agents Chemother; 2014 Oct; 58(10):6242-50. PubMed ID: 25114132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strong Increase in Moxifloxacin Resistance Rate among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China, 2007 to 2013.
    Xia H; Zheng Y; Liu D; Wang S; He W; Zhao B; Song Y; Ou X; Zhou Y; van den Hof S; Cobelens F; Zhao Y
    Microbiol Spectr; 2021 Dec; 9(3):e0040921. PubMed ID: 34851179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.
    De Logu A; Onnis V; Saddi B; Congiu C; Schivo ML; Cocco MT
    J Antimicrob Chemother; 2002 Feb; 49(2):275-82. PubMed ID: 11815568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.
    Lai CC; Tan CK; Huang YT; Chou CH; Hung CC; Yang PC; Luh KT; Hsueh PR
    Clin Infect Dis; 2008 Oct; 47(7):e57-63. PubMed ID: 18715157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First-line anti-tuberculosis drug resistance trends of Mycobacterium tuberculosis complex isolates. A tertiary hospital study in Turkey.
    Yazısız H; Hırçın Cenger D; Yazısız V; Kılıç L; Altın S
    Tuberk Toraks; 2019 Jun; 67(2):92-101. PubMed ID: 31414639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Resistance of Mycobacterium tuberculosis in Mexican patients. I. Clinical features and risk factors].
    Sifuentes-Osornio J; Ponce-de-León LA; Camacho-Mezquita FE; Bobadilla-del-Valle JM; Infante-Suárez ML; Ramírez-Fernández N; Hernández-Gómez L; Nelson AM
    Rev Invest Clin; 1995; 47(4):273-81. PubMed ID: 8525129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knocking out salicylate biosynthesis genes in Mycobacterium smegmatis induces hypersensitivity to p-aminosalicylate (PAS).
    Nagachar N; Ratledge C
    FEMS Microbiol Lett; 2010 Oct; 311(2):193-9. PubMed ID: 20735479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and Dose Optimization Strategies of Para-Aminosalicylic Acid in Children with Rifampicin-Resistant Tuberculosis.
    van der Laan LE; Garcia-Prats AJ; Schaaf HS; Chirehwa M; Winckler JL; Mao J; Draper HR; Wiesner L; Norman J; McIlleron H; Donald PR; Hesseling AC; Denti P
    Antimicrob Agents Chemother; 2022 Jun; 66(6):e0226421. PubMed ID: 35506699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.